Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
- PMID: 29678491
- DOI: 10.1016/j.jsbmb.2018.04.008
Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
Abstract
Polycystic ovary syndrome (PCOS) is an endocrine disorder, afflicting females of reproductive age. This syndrome leads to infertility, insulin resistance, obesity, and cardiovascular problems, including a litany of other health issues. PCOS is a polygenic, polyfactorial, systemic, inflammatory, dysregulated steroid state, autoimmune disease, manifesting largely due to lifestyle errors. The advent of biochemical tests and ultrasound scanning has enabled the detection of PCOS in the affected females. Subsequently, a huge amount of insight on PCOS has been garnered in recent times. Interventions like oral contraceptive pills, metformin, and hormone therapy have been developed to bypass or reverse the ill effects of PCOS. However, lifestyle correction to prevent aberrant immune activation and to minimize the exposure to inflammatory agents, appears to be the sustainable therapy of PCOS. This holistic review with multiple hypotheses might facilitate to devise better PCOS management approaches.
Keywords: Amenorrhea; Anovulation; Endocrine disorder; Hyperandrogenism; Hyperprolactinemia; Polycystic ovary syndrome (PCOS).
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS).Life Sci. 2019 Jul 1;228:167-175. doi: 10.1016/j.lfs.2019.04.046. Epub 2019 Apr 25. Life Sci. 2019. PMID: 31029778 Review.
-
Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.Endocrinology. 2014 Aug;155(8):3146-59. doi: 10.1210/en.2014-1196. Epub 2014 May 30. Endocrinology. 2014. PMID: 24877633
-
Obesity and the polycystic ovary syndrome.Minerva Endocrinol. 2007 Sep;32(3):129-40. Minerva Endocrinol. 2007. PMID: 17912153 Review.
-
Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.Hum Reprod Update. 2015 Sep-Oct;21(5):560-74. doi: 10.1093/humupd/dmv025. Epub 2015 Jun 9. Hum Reprod Update. 2015. PMID: 26060208 Review.
-
Endocrine characteristics of polycystic ovary syndrome (PCOS).Indian J Exp Biol. 2003 Jul;41(7):694-700. Indian J Exp Biol. 2003. PMID: 15255372 Review.
Cited by
-
Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.BMC Complement Med Ther. 2023 Dec 15;23(1):458. doi: 10.1186/s12906-023-04280-6. BMC Complement Med Ther. 2023. PMID: 38102584 Free PMC article.
-
Dietary α-Linolenic Acid-Rich Flaxseed Oil Exerts Beneficial Effects on Polycystic Ovary Syndrome Through Sex Steroid Hormones-Microbiota-Inflammation Axis in Rats.Front Endocrinol (Lausanne). 2020 May 27;11:284. doi: 10.3389/fendo.2020.00284. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32670195 Free PMC article.
-
Evaluation of the expression profile of mRNAs and lncRNAs in cumulus cells associated with polycystic ovary syndrome and pregnancy.Iran J Basic Med Sci. 2023;26(10):1144-1154. doi: 10.22038/IJBMS.2023.67564.14806. Iran J Basic Med Sci. 2023. PMID: 37736513 Free PMC article.
-
Minerals and the Menstrual Cycle: Impacts on Ovulation and Endometrial Health.Nutrients. 2024 Mar 29;16(7):1008. doi: 10.3390/nu16071008. Nutrients. 2024. PMID: 38613041 Free PMC article. Review.
-
Metformin inhibits ovarian granular cell pyroptosis through the miR-670-3p/NOX2/ROS pathway.Aging (Albany NY). 2023 May 25;15(10):4429-4443. doi: 10.18632/aging.204745. Epub 2023 May 25. Aging (Albany NY). 2023. PMID: 37244286 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical